Evaluation of Atorvastatin Treatment on Carotid Plaque.

Stopped early · Phase 3

Conditions studied: Cardiovascular Diseases

In brief

The purpose of the study is to evaluate the effect of 18 months treatment with atorvastatin 80mg or atorvastatin 10mg on the carotid vessel plaque morphology, in particular, the effect on evident necrotic lipid rich core of the plaque in patients.

Key facts

Study ID

NCT00343655

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

160

Starts

2007-01-01

Expected to finish

2007-08-01

Last updated by the study team

2021-02-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects with measurable carotid plaque with lipid and are eligible for statin therapy.

You may not qualify if…

• Subjects at higher risk for cardiovascular disease with a screen LDL-cholesterol greater than 120 mg/dL,
• Subjects currently on high dose statin, and
• Subjects with contraindications for MRI or statin therapy.

Where it is running

• Pfizer Investigational Site — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.